Q6DE87 (CHK1_XENLA) Reviewed, UniProtKB/Swiss-Prot
Last modified
December 14, 2011.
Version 66.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Serine/threonine-protein kinase Chk1 EC=2.7.11.1 Alternative name(s): CHK1 checkpoint homolog Checkpoint kinase-1 Short name=xChk1 | ||||
| Gene names |
| ||||
| Organism | Xenopus laevis (African clawed frog) | ||||
| Taxonomic identifier | 8355 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Amphibia › Batrachia › Anura › Mesobatrachia › Pipoidea › Pipidae › Xenopodinae › Xenopus › Xenopus |
Protein attributes
| Sequence length | 474 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Serine/threonine-protein kinase which is required for checkpoint-mediated cell cycle arrest and activation of DNA repair in response to the presence of DNA damage or unreplicated DNA. May also negatively regulate cell cycle progression during unperturbed cell cycles. This regulation is achieved by a number of mechanisms that together help to preserve the integrity of the genome. Recognizes the substrate consensus sequence [R-X-X-S/T]. Phosphorylates wee1 at 'Ser-549' and cdc25c at 'Ser-287', which creates binding sites for 14-3-3 proteins which activate wee1 and inhibit cdc25c. Phosphorylates cdc25a at 'Ser-504' which prevents the interaction of cdc25a with CDK2-cyclin E1, CDC2-cyclin A1 and CDC2-cyclin B1. This inhibitory effect does not require 14-3-3 protein binding. Activation of wee1 and inhibition of CDC25 results in increased inhibitory tyrosine phosphorylation of CDK-cyclin complexes and consequent inhibition of cell cycle progression. May promote DNA repair, regulate chromatin assembly and the transcription of genes that regulate cell-cycle progression. May also play a role in replication fork maintenance. Ref.1 Ref.2 Ref.3 Ref.6 Ref.7 Ref.8 Ref.9 Ref.10 Ref.13 Ref.14 |
| Catalytic activity | ATP + a protein = ADP + a phosphoprotein. |
| Enzyme regulation | Activated through phosphorylation by atr or atm in response to DNA damage or inhibition of DNA replication By similarity. Ref.6 |
| Subunit structure | Interacts with and phosphorylates clspn, an adapter protein that regulates the ATR-dependent phosphorylation of chek1. Ref.7 Ref.11 Ref.12 Ref.15 |
| Subcellular location | Nucleus. Cytoplasm. Cytoplasm › cytoskeleton › centrosome By similarity Ref.8 Ref.16. |
| Developmental stage | Expressed throughout development. Transiently activated by ATR-mediated phosphorylation from the midblastula transition (MBT) to the initial gastrula stage. Developmentally regulated activation of the DNA replication checkpoint may occur as the nucleo-cytoplasmic ratio increases and maternal replication factors are depleted. Elongation of the embryonic cell cycle may allow time for the transcription of genes that initiate the switch from maternal to zygotic control of embryogenesis. Ref.2 Ref.3 Ref.10 Ref.13 Ref.14 |
| Domain | The autoinhibitory region (AIR) binds to the kinase domain and inhibits its activity. Ref.11 Ref.16 |
| Post-translational modification | Phosphorylated by atm in response to ionizing irradiation By similarity. Phosphorylated by atr at Thr-314, Ser-344, Ser-356 and Ser-365 in response to various stimuli that cause checkpoint activation. Phosphorylation impairs binding of the C-terminal autoinhibitory region (AIR) to the kinase domain and thereby enhances kinase activity. Ref.1 Ref.3 Ref.6 Ref.7 Ref.8 Ref.11 Ref.13 Ref.15 Ref.16 |
| Sequence similarities | Belongs to the protein kinase superfamily. CAMK Ser/Thr protein kinase family. NIM1 subfamily. Contains 1 protein kinase domain. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 474 | 474 | Serine/threonine-protein kinase Chk1 | PRO_0000085852 | |||||
Regions | |||||||||
| Domain | 9 – 265 | 257 | Protein kinase | ||||||
| Nucleotide binding | 15 – 23 | 9 | ATP By similarity | ||||||
| Region | 1 – 265 | 265 | Interaction with CLSPN | ||||||
| Region | 360 – 474 | 115 | Autoinhibitory region | ||||||
| Region | 367 – 474 | 108 | Required for nuclear localization | ||||||
Sites | |||||||||
| Active site | 130 | 1 | Proton acceptor By similarity | ||||||
| Binding site | 38 | 1 | ATP By similarity | ||||||
Amino acid modifications | |||||||||
| Modified residue | 314 | 1 | Phosphothreonine; by ATR Ref.6 | ||||||
| Modified residue | 344 | 1 | Phosphoserine; by ATR Ref.6 Ref.11 Ref.13 Ref.15 Ref.16 | ||||||
| Modified residue | 356 | 1 | Phosphoserine; by ATR Ref.6 | ||||||
| Modified residue | 365 | 1 | Phosphoserine; by ATR Ref.6 | ||||||
Experimental info | |||||||||
| Mutagenesis | 54 | 1 | K → A: Abolishes interaction with CLSPN. Abrogates phosphorylation at S-344 and kinase activation during checkpoint signaling. Ref.11 | ||||||
| Mutagenesis | 129 | 1 | R → A: Abolishes interaction with CLSPN, abrogates phosphorylation at S-344 and abolishes kinase activity. Ref.11 | ||||||
| Mutagenesis | 135 | 1 | N → A: Abolishes kinase activity; no effect on interaction with CLSPN. Ref.1 Ref.7 Ref.11 | ||||||
| Mutagenesis | 148 | 1 | D → A: Abolishes kinase activity. Ref.2 | ||||||
| Mutagenesis | 153 | 1 | T → A: Abolishes interaction with CLSPN. Abrogates phosphorylation at S-344 and kinase activation during checkpoint signaling. Ref.11 | ||||||
| Mutagenesis | 162 | 1 | R → A: Abolishes interaction with CLSPN and kinase activation during checkpoint signaling. No effect on phosphorylation at S-344. Ref.11 | ||||||
| Mutagenesis | 314 | 1 | T → A: Abrogates phosphorylation and activation during checkpoint signaling; when associated with A-344; A-356 and A-365. Ref.7 Ref.16 | ||||||
| Mutagenesis | 314 | 1 | T → D: Impairs autoinhibition by the AIR domain; when associated with D-344; D-356 and D-365. Ref.7 Ref.16 | ||||||
| Mutagenesis | 314 | 1 | T → E: Impairs autoinhibition by the AIR domain; when associated with E-344; E-356 and E-365. Ref.7 Ref.16 | ||||||
| Mutagenesis | 344 | 1 | S → A: Abrogates phosphorylation and activation during checkpoint signaling; when associated with A-314; A-356 and A-365. Ref.7 Ref.16 | ||||||
| Mutagenesis | 344 | 1 | S → D: Impairs autoinhibition by the AIR domain; when associated with D-314; D-356 and D-365. Ref.7 Ref.16 | ||||||
| Mutagenesis | 344 | 1 | S → E: Impairs autoinhibition by the AIR domain; when associated with E-314; E-356 and E-365. Ref.7 Ref.16 | ||||||
| Mutagenesis | 356 | 1 | S → A: Abrogates phosphorylation and activation during checkpoint signaling; when associated with A-314; A-344 and A-365. Ref.7 Ref.16 | ||||||
| Mutagenesis | 356 | 1 | S → D: Impairs autoinhibition by the AIR domain; when associated with D-314; D-344 and D-365. Ref.7 Ref.16 | ||||||
| Mutagenesis | 356 | 1 | S → E: Impairs autoinhibition by the AIR domain; when associated with E-314; E-344 and E-365. Ref.7 Ref.16 | ||||||
| Mutagenesis | 365 | 1 | S → A: Abrogates phosphorylation and activation during checkpoint signaling; when associated with A-314; A-344 and A-356. Ref.7 Ref.16 | ||||||
| Mutagenesis | 365 | 1 | S → D: Impairs autoinhibition by the AIR domain; when associated with D-314; D-344 and D-356. Ref.7 Ref.16 | ||||||
| Mutagenesis | 365 | 1 | S → E: Impairs autoinhibition by the AIR domain; when associated with E-314; E-344 and E-356. Ref.7 Ref.16 | ||||||
| Mutagenesis | 374 – 380 | 7 | Missing: Induces hyperphosphorylation and enhances kinase activity. Ref.5 | ||||||
| Mutagenesis | 374 – 375 | 2 | KR → AA: Impairs autoinhibition and abrogates nuclear localization. | ||||||
| Mutagenesis | 377 | 1 | T → A: Induces hyperphosphorylation and enhances kinase activity and cell cycle arrest. Abolishes interaction with CLSPN. Ref.5 Ref.11 | ||||||
| Mutagenesis | 377 | 1 | T → E: Enhances kinase activity. Ref.5 Ref.11 | ||||||
| Mutagenesis | 451 – 452 | 2 | KR → AA: Enhances kinase activity. | ||||||
| Mutagenesis | 456 – 458 | 3 | KIK → AAA: Enhances kinase activity and abrogates nuclear localization. Ref.16 | ||||||
| Sequence conflict | 165 | 1 | N → S in AAC64262. Ref.1 | ||||||
| Sequence conflict | 165 | 1 | N → S in BAA34058. Ref.2 | ||||||
| Sequence conflict | 230 – 231 | 2 | Missing in BAA34058. Ref.2 | ||||||
| Sequence conflict | 232 | 1 | K → E in AAF00098. Ref.3 | ||||||
| Sequence conflict | 238 | 1 | P → L in BAA34058. Ref.2 | ||||||
| Sequence conflict | 243 | 1 | C → G in AAC64262. Ref.1 | ||||||
| Sequence conflict | 243 | 1 | C → G in BAA34058. Ref.2 | ||||||
| Sequence conflict | 307 | 1 | Missing in AAF00098. Ref.3 | ||||||
| Sequence conflict | 307 | 1 | Missing in AAH77249. Ref.4 | ||||||
| Sequence conflict | 331 – 333 | 3 | YID → DIN in AAC64262. Ref.1 | ||||||
| Sequence conflict | 331 – 333 | 3 | YID → DIN in BAA34058. Ref.2 | ||||||
| Sequence conflict | 472 – 473 | 2 | PD → SA in AAC64262. Ref.1 | ||||||
| Sequence conflict | 472 – 473 | 2 | PD → SA in BAA34058. Ref.2 | ||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "The Xenopus Chk1 protein kinase mediates a caffeine-sensitive pathway of checkpoint control in cell-free extracts." Kumagai A., Guo Z., Emami K.H., Wang S.X., Dunphy W.G. J. Cell Biol. 142:1559-1569(1998) [PubMed: 9744884] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, PHOSPHORYLATION, MUTAGENESIS OF ASN-135. |
| [2] | "Involvement of Chk1 kinase in prophase I arrest of Xenopus oocytes." Nakajo N., Oe T., Uto K., Sagata N. Dev. Biol. 207:432-444(1999) [PubMed: 10068474] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, DEVELOPMENTAL STAGE, MUTAGENESIS OF ASP-148. Tissue: Ovary. |
| [3] | "Dissection of the XChk1 signaling pathway in Xenopus laevis embryos." Kappas N.C., Savage P., Chen K.C., Walls A.T., Sible J.C. Mol. Biol. Cell 11:3101-3108(2000) [PubMed: 10982403] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, DEVELOPMENTAL STAGE, PHOSPHORYLATION. |
| [4] | NIH - Xenopus Gene Collection (XGC) project Submitted (JUL-2004) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Ovary. |
| [5] | "Activation of Xenopus Chk1 by mutagenesis of threonine-377." Wang S.X., Dunphy W.G. FEBS Lett. 487:277-281(2000) [PubMed: 11150524] [Abstract] Cited for: MUTAGENESIS OF 374-LYS--PHE-380 AND THR-377. |
| [6] | "Requirement for Atr in phosphorylation of Chk1 and cell cycle regulation in response to DNA replication blocks and UV-damaged DNA in Xenopus egg extracts." Guo Z., Kumagai A., Wang S.X., Dunphy W.G. Genes Dev. 14:2745-2756(2000) [PubMed: 11069891] [Abstract] Cited for: FUNCTION, ENZYME REGULATION, PHOSPHORYLATION AT THR-314; SER-344; SER-356 AND SER-365. |
| [7] | "Claspin, a novel protein required for the activation of Chk1 during a DNA replication checkpoint response in Xenopus egg extracts." Kumagai A., Dunphy W.G. Mol. Cell 6:839-849(2000) [PubMed: 11090622] [Abstract] Cited for: FUNCTION, INTERACTION WITH CLSPN, PHOSPHORYLATION, MUTAGENESIS OF ASN-135; THR-314; SER-344; SER-356 AND SER-365. |
| [8] | "Cytoplasmic occurrence of the Chk1/Cdc25 pathway and regulation of Chk1 in Xenopus oocytes." Oe T., Nakajo N., Katsuragi Y., Okazaki K., Sagata N. Dev. Biol. 229:250-261(2001) [PubMed: 11133168] [Abstract] Cited for: FUNCTION, SUBCELLULAR LOCATION, PHOSPHORYLATION, AUTOINHIBITION. |
| [9] | "Positive regulation of Wee1 by Chk1 and 14-3-3 proteins." Lee J., Kumagai A., Dunphy W.G. Mol. Biol. Cell 12:551-563(2001) [PubMed: 11251070] [Abstract] Cited for: FUNCTION. |
| [10] | "Chk1 is activated transiently and targets Cdc25A for degradation at the Xenopus midblastula transition." Shimuta K., Nakajo N., Uto K., Hayano Y., Okazaki K., Sagata N. EMBO J. 21:3694-3703(2002) [PubMed: 12110582] [Abstract] Cited for: FUNCTION, DEVELOPMENTAL STAGE. |
| [11] | "Phosphorylated claspin interacts with a phosphate-binding site in the kinase domain of Chk1 during ATR-mediated activation." Jeong S.-Y., Kumagai A., Lee J., Dunphy W.G. J. Biol. Chem. 278:46782-46788(2003) [PubMed: 12963733] [Abstract] Cited for: DOMAIN FOR INTERACTION WITH CLSPN, PHOSPHORYLATION AT SER-344, MUTAGENESIS OF LYS-54; ARG-129; ASN-135; THR-153; ARG-162 AND THR-377. |
| [12] | "Repeated phosphopeptide motifs in claspin mediate the regulated binding of Chk1." Kumagai A., Dunphy W.G. Nat. Cell Biol. 5:161-165(2003) [PubMed: 12545175] [Abstract] Cited for: INTERACTION WITH CLSPN. |
| [13] | "The DNA damage checkpoint in embryonic cell cycles is dependent on the DNA-to-cytoplasmic ratio." Conn C.W., Lewellyn A.L., Maller J.L. Dev. Cell 7:275-281(2004) [PubMed: 15296723] [Abstract] Cited for: FUNCTION, DEVELOPMENTAL STAGE, PHOSPHORYLATION AT SER-344. |
| [14] | "Chk1, but not Chk2, inhibits Cdc25 phosphatases by a novel common mechanism." Uto K., Inoue D., Shimuta K., Nakajo N., Sagata N. EMBO J. 23:3386-3396(2004) [PubMed: 15272308] [Abstract] Cited for: FUNCTION, DEVELOPMENTAL STAGE. |
| [15] | "Claspin and the activated form of ATR-ATRIP collaborate in the activation of Chk1." Kumagai A., Kim S.-M., Dunphy W.G. J. Biol. Chem. 279:49599-49608(2004) [PubMed: 15371427] [Abstract] Cited for: INTERACTION WITH CLSPN, PHOSPHORYLATION AT SER-344. |
| [16] | "Regulation of Chk1 kinase by autoinhibition and ATR-mediated phosphorylation." Katsuragi Y., Sagata N. Mol. Biol. Cell 15:1680-1689(2004) [PubMed: 14767054] [Abstract] Cited for: SUBCELLULAR LOCATION, DOMAIN AIR, PHOSPHORYLATION AT SER-344, MUTAGENESIS OF THR-314; SER-344; SER-356; SER-365; 374-LYS-ARG-375; 451-LYS-ARG-452 AND 456-LYS--LYS-458. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AF053120 mRNA. Translation: AAC64262.1. AB019218 mRNA. Translation: BAA34058.1. AF117816 mRNA. Translation: AAF00098.1. BC077249 mRNA. Translation: AAH77249.1. |
| RefSeq | NP_001082039.1. NM_001088570.1. |
| UniGene | Xl.406. |
3D structure databases | |
| ProteinModelPortal | Q6DE87. |
| SMR | Q6DE87. Positions 3-272. |
| ModBase | Search... |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| GeneID | 398191. |
| KEGG | xla:398191. |
Organism-specific databases | |
| CTD | 1111. |
| Xenbase | XB-GENE-866102. chek1. |
Phylogenomic databases | |
| HOVERGEN | HBG002590. |
Family and domain databases | |
| InterPro | IPR011009. Kinase-like_dom. IPR000719. Prot_kinase_cat_dom. IPR017441. Protein_kinase_ATP_BS. IPR017442. Se/Thr_kinase-like_dom. IPR008271. Ser/Thr_kinase_AS. IPR002290. Ser/Thr_kinase_dom. [Graphical view] |
| KO | K02216. |
| Pfam | PF00069. Pkinase. 1 hit. [Graphical view] |
| SMART | SM00220. S_TKc. 1 hit. [Graphical view] |
| SUPFAM | SSF56112. Kinase_like. 1 hit. |
| PROSITE | PS00107. PROTEIN_KINASE_ATP. 1 hit. PS50011. PROTEIN_KINASE_DOM. 1 hit. PS00108. PROTEIN_KINASE_ST. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Entry information
| Entry name | CHK1_XENLA | ||||||||
| Accession | Primary (citable) accession number: Q6DE87 Secondary accession number(s): Q78CK1, Q78DQ2, Q9YI18 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
Relevant documents
| SIMILARITY comments Index of protein domains and families |

Clusters with